Interpace BioPharma’s product commercialization services are a viable option for several types of companies and their pharmaceutical, biotech, medical device, or diagnostics products.

Company candidates include:

• Companies seeking to out license products
• Established companies seeking to enter the US market
• Start up companies

Product candidates include:

• Pharmaceutical, biopharmaceutical, medical device, and diagnostic products
• Phase III products with or without FDA approval*
• Approved products: launched or ready for launch
• Late life cycle and mature portfolio products demanding full or supplementary support, including fully or partially integrated commercial resources
• Sub-optimized specialty products with positive NPV when appropriate resources are applied